Witnessing the stock’s movement on the chart, on Wednesday, InMed Pharmaceuticals Inc (NASDAQ: INM) had a quiet start as it plunged -5.85% to $4.51, before settling in for the price of $4.79 at the close. Taking a more long-term approach, INM posted a 52-week range of $2.41-$15.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 58.16%. Meanwhile, its Annual Earning per share during the time was 53.87%. This publicly-traded company’s shares outstanding now amounts to $0.67 million, simultaneously with a float of $0.17 million. The organization now has a market capitalization sitting at $3.27 million. At the time of writing, stock’s 50-day Moving Average stood at $4.83, while the 200-day Moving Average is $5.24.
InMed Pharmaceuticals Inc (INM) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. InMed Pharmaceuticals Inc’s current insider ownership accounts for 0.66%, in contrast to 125.25% institutional ownership. According to the most recent insider trade that took place on Jul 31 ’24, this organization’s Consultant sold 240 shares at the rate of 0.18, making the entire transaction reach 42 in total value, affecting insider ownership by 0. Preceding that transaction, on Feb 21 ’24, Company’s Director bought 37,500 for 0.39, making the whole transaction’s value amount to 14,625. This particular insider is now the holder of 38,258 in total.
InMed Pharmaceuticals Inc (NASDAQ: INM) Trading Performance Indicators
Let’s observe the current performance indicators for InMed Pharmaceuticals Inc (INM). It’s Quick Ratio in the last reported quarter now stands at 4.22. The Stock has managed to achieve an average true range (ATR) of 0.42. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.66.
In the same vein, INM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -14.34.
Technical Analysis of InMed Pharmaceuticals Inc (INM)
Going through the that latest performance of [InMed Pharmaceuticals Inc, INM]. Its last 5-days volume of 38480.0 indicated improvement to the volume of 38480.0 it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 44.51% While, its Average True Range was 0.40.
Raw Stochastic average of InMed Pharmaceuticals Inc (INM) in the period of the previous 100 days is set at 13.26%, which indicates a major fall in contrast to 30.76% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 94.12% that was lower than 198.58% volatility it exhibited in the past 100-days period.
